Biopsy Needle Market Size & Share, by Product (Biopsy Needle Guns, Biopsy Needles); Application; End-use - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 6404
  • Published Date: Sep 09, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Biopsy Needle Market size is estimated at USD 1.7 billion in 2024 and is likely to exceed USD 3.8 billion by the end of 2037, expanding at over 7.1% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of biopsy needle is evaluated at USD 1.9 billion.

The biopsy needle market is rapidly expanding due to the rising prevalence of various chronic diseases. Biopsy needles play a crucial role in the healthcare sector, enabling healthcare professionals to gain accurate diagnosis results and develop effective treatment schedules. With advancements in technology and continuous research and development in this domain, the focus is shifting toward minimally invasive procedures, expanding healthcare infrastructure, and result-oriented outcomes. Furthermore, automated and image-guided biopsy needles induce market demand enhancing precision and reducing tissue trauma. This market emphasizes needle designing, manufacturing, and distribution to conduct biopsy procedures for the end users with an effortless and time-saving approach leading to improved diagnostics accuracy and reliability.


Biopsy Needle Market Overview
Get more information on this report: Request Free Sample PDF

Biopsy Needle Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising prevalence of types of cancer: Rising cases of cancer globally is one of the major factors boosting the biopsy needles market growth. According to the WHO, cancer was the second leading cause of death, worldwide, in 2018, accounting for approximately 9.6 million deaths. Additionally, environmental and lifestyle factors, exposure to carcinogens, and unhealthy food habits contribute to the growing cancer burden, underscoring the need for advanced biopsy technologies that support timely and accurate diagnosis and its treatments. This has resulted in increasing demand for biopsy needles. Early detection through biopsy needles helps to improve treatment outcomes and increase survival rates.
  •  Expanding applications of biopsy needles: The wide usage of biopsy needles in medical fields such as neurology, ophthalmology, gastroenterology, cardiology, and pediatric applications is driving its market growth. In neurology, biopsy needles are used to detect and diagnose brain tumors, in ophthalmology, they are used in treating eye diseases. In gastroenterology, the biopsy needle plays a vital role in treating liver diseases and pancreatic cancers. Additionally, biopsy needles perform various functions aiding research settings to study and develop disease mechanisms and new treatments respectively. The constant breakthroughs in the biopsy needle market are broadening its applications.
  • Growing demand for minimally invasive procedures: The growing awareness and demand for minimally invasive procedures are driving demand for innovations in the biopsy needle market. Patients and healthcare professionals strive to reduce recovery time and complications by experiencing less pain, improved satisfaction, and reduced hospital days. Moreover, minimally invasive procedures result in high accuracy and are cost-effective. As the demand is increasing, manufacturers are deemed to be more specific regarding needle designing, handling, and configurations to meet the requirements and revolutionize the biopsy and diagnostics procedures.

Challenges

  • Risk of complications and infections: The concern over the utilization of biopsy needles causing complications and infections during treatment is likely to hinder the growth in the market. Bacterial or viral infections are common infections that patients might experience at the biopsy sites, abscesses, sepsis, and cellulitis. Additionally, complications such as organ damage, bleeding, and tissue trauma can lead to severe health issues for the patient risking his life.
  • Regulatory challenges and compliance issues: Regulatory challenges and lack of adherence to compliance pose a significant obstacle in the biopsy needle market, as manufacturers and healthcare providers are responsible for scrutinizing complex regulatory frameworks. Moreover, compliance with regulations related to patient data privacy and security is essential to be maintained. Failure to comply with these details may lead to fines, legal charges, and damaging the reputation.

Biopsy Needle Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

7.1%

Base Year Market Size (2024)

USD 1.7 billion

Forecast Year Market Size (2037)

USD 3.8 billion

Regional scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Biopsy Needle Segmentation

Product (Biopsy Needle Guns, Biopsy Needles)

Biopsy needle guns segment is poised to hold over 64.1 % biopsy needle market share by the end of 2037. Biopsy needle guns are crucial in treating patients in procedures requiring rapid, accurate, and efficient results. The features associated with biopsy guns that make the procedure more effortless are their adjustable needle depth, handheld designs, and availability in various sizes. Biopsy needle guns offer enhanced accuracy, and reduce risks and complications, with valuable outcomes for healthcare professionals, and practitioners. The demand for biopsy guns has improved efficiency in healthcare settings and has led the field toward a revolutionized and advanced approach to diagnostics.

Application (Cancer, Autoimmune Disorder, Infectious Diseases)

The cancer segment is expected to register a staggering CAGR throughout the forecast period. Breast cancer and prostate cancer are the most highlighted sub-segments of cancer applications. The diverse range of emerging cancer cases has increased the demand for biopsy needles making it a significant diagnostics tool. In July 2021, GE Healthcare installed Serena Bright, the first-contrast-guided biopsy solution in 5 leading hospitals in the U.S. to support clinicians and patients in their fight against breast cancer.

Our in-depth analysis of the biopsy needle market includes the following segments:

Product

  • Biopsy Needle Guns
  • Biopsy Needles

Application

  • Cancer
  • Autoimmune Disorder
  •  Infectious Diseases

End user

  • Hospitals
  • Ambulatory
  • Surgical Centers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Biopsy Needle Industry - Regional Synopsis

North America Market Statistics

North America biopsy needle market is estimated to account for revenue share of more than 41.2% by the end of 2037 owing to the presence of advanced healthcare infrastructure and significant investments in medical research and development, fostering innovation and adoption of cutting-edge biopsy technologies. A robust regulatory framework enhancing trust and confidence among healthcare professionals and patients is expected to further boost the market growth.

The biopsy needle market in the U.S. is expected to register a significant revenue share during the forecast period owing to increasing prevalence of several chronic diseases, rising availability of different types of biopsy needles, and presence of advanced healthcare infrastructure. Moreover, the public and private sectors are heavily investing in R&D activities to develop and launch advanced biopsy needles for better results.

APAC Market Analysis

Asia Pacific biopsy needle market is driven by a significant increase in the demand for minimally invasive procedures and a rise in cancer across the region. Factors that add to this surge include increasing investments in liquid biopsy techniques, rising inclination toward personalized healthcare, and a high adoption of advanced diagnostic tools in healthcare centers in APAC.

In India, the biopsy needle market is likely to experience an upsurge owing to enhancing healthcare system infrastructure, and government initiatives. Key Players in this region including Boston Scientific and Medtronic play a vital role in revolutionizing the scenario of diagnostics procedures and preparation of systematized treatment plans.

Research Nester
Biopsy Needle Market Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Biopsy Needle Landscape

    The biopsy needle market is highly competitive, consisting of key players operating at global and regional levels. The key players are focused on developing advanced tools and products to cater to the rising demand for effective diagnostic tools. These key players are also adopting several strategies such as joint ventures, acquisitions, and product launches to sustain their market position and enhance their product base. Here’s a list of key players operating in the global market:

    • Argon Medical Devices Inc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Becton
    • Cardinal Health
    • Olympus Corporation
    • Argon Medical Devices Inc
    • Devicor Medical Products, Inc
    • B. Braun Melsungen AG
    • Cook Group Incorporated
    • FUJIFILM Holdings Corporation
    • Dickinson and Company
    • Stryker Corporation
    • INRAD, Inc.

In the News

  • In May 2024, Cook Medical announced the launch of EchoTipAcuCore, an endoscopic ultrasound biopsy needle for precision gastrointestinal lesion biopsies. The needle’s tip is made of a cobalt-chromium alloy which allows healthcare experts to puncture tissue with flexibility and controlled precision.
  • In May 2022, Argon Medical, a leading market player in the U.S. partnered with Terum India to expand its product base including IVC filters, and bone and soft tissue biopsy needles.

Author Credits:  Radhika Pawar


  • Report ID: 6404
  • Published Date: Sep 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the biopsy needle market was over USD 1.7 billion.

The market size of the biopsy needle landscape is projected to surpass USD 3.8 billion by the end of 2037 expanding at a CAGR of 7.1% during the forecast period i.e., between 2025-2037.

The major players in the market are Becton, Medtronic Plc, Cardinal Health, Hologic Inc., Olympus Corporation, Argon Medical Devices Inc., Devicor Medical Products, Inc., Cook Group Incorporated, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Dickinson and Company, and INRAD, Inc.

In terms of product, the biopsy needle guns segment is anticipated to garner the largest market share of 64.1% by 2037 and display significant growth opportunities during 2025-2037.

The market in North America is projected to hold the largest revenue share of 41.2% by the end of 2037 and provide more business opportunities in the future.
Biopsy Needle Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample